The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia. [electronic resource]
Producer: 20110609Description: 638-47 p. digitalISSN:- 1476-5551
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor -- genetics
- Cytokines -- metabolism
- Female
- Gene Expression Profiling
- Gene Expression Regulation, Leukemic -- genetics
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- genetics
- Male
- Middle Aged
- Oligonucleotide Array Sequence Analysis
- Oligoribonucleotides, Antisense -- therapeutic use
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- RNA, Messenger -- genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.